Attached files

file filename
S-1 - REGISTRATION STATEMENT ON FORM S-1 - KalVista Pharmaceuticals, Inc.d781411ds1.htm
EX-3.3 - EX-3.3 - KalVista Pharmaceuticals, Inc.d781411dex33.htm
EX-4.3 - EX-4.3 - KalVista Pharmaceuticals, Inc.d781411dex43.htm
EX-4.4 - EX-4.4 - KalVista Pharmaceuticals, Inc.d781411dex44.htm
EX-4.5.1 - EX-4.5.1 - KalVista Pharmaceuticals, Inc.d781411dex451.htm
EX-3.1 - EX-3.1 - KalVista Pharmaceuticals, Inc.d781411dex31.htm
EX-4.6 - EX-4.6 - KalVista Pharmaceuticals, Inc.d781411dex46.htm
EX-10.4 - EX-10.4 - KalVista Pharmaceuticals, Inc.d781411dex104.htm
EX-10.6 - EX-10.6 - KalVista Pharmaceuticals, Inc.d781411dex106.htm
EX-23.1 - EX-23.1 - KalVista Pharmaceuticals, Inc.d781411dex231.htm
EX-10.5.5 - EX-10.5.5 - KalVista Pharmaceuticals, Inc.d781411dex1055.htm
EX-10.5.1 - EX-10.5.1 - KalVista Pharmaceuticals, Inc.d781411dex1051.htm
EX-10.5.4 - EX-10.5.4 - KalVista Pharmaceuticals, Inc.d781411dex1054.htm
EX-10.12 - EX-10.12 - KalVista Pharmaceuticals, Inc.d781411dex1012.htm
EX-10.5.2 - EX-10.5.2 - KalVista Pharmaceuticals, Inc.d781411dex1052.htm
EX-10.7 - EX-10.7 - KalVista Pharmaceuticals, Inc.d781411dex107.htm
EX-4.7 - EX-4.7 - KalVista Pharmaceuticals, Inc.d781411dex47.htm
EX-10.1 - EX-10.1 - KalVista Pharmaceuticals, Inc.d781411dex101.htm
EX-10.2 - EX-10.2 - KalVista Pharmaceuticals, Inc.d781411dex102.htm
EX-4.5.2 - EX-4.5.2 - KalVista Pharmaceuticals, Inc.d781411dex452.htm
EX-10.8 - EX-10.8 - KalVista Pharmaceuticals, Inc.d781411dex108.htm
EX-10.9 - EX-10.9 - KalVista Pharmaceuticals, Inc.d781411dex109.htm
EX-10.13 - EX-10.13 - KalVista Pharmaceuticals, Inc.d781411dex1013.htm
EX-10.14 - EX-10.14 - KalVista Pharmaceuticals, Inc.d781411dex1014.htm
EX-10.5.3 - EX-10.5.3 - KalVista Pharmaceuticals, Inc.d781411dex1053.htm
EX-10.11 - EX10.11 - KalVista Pharmaceuticals, Inc.d781411dex1011.htm
EX-10.15 - EX-10.15 - KalVista Pharmaceuticals, Inc.d781411dex1015.htm
EX-10.10 - EX-10.10 - KalVista Pharmaceuticals, Inc.d781411dex1010.htm

Exhibit 4.5.3


[October 26, 2011 Warrant]

THIS SECOND AMENDMENT TO WARRANT TO PURCHASE STOCK (this Amendment) is deemed effective as of February 12th, 2013, by and between SVB FINANCIAL GROUP (SVB Financial Group or Holder) and CARBYLAN BIOSURGERY, INC., a Delaware corporation (the Company).


A.       The Company issued the Warrant to Purchase Stock to Silicon Valley Bank on October 26, 2011, which Silicon Valley Bank subsequently assigned to SVB Financial Group, (as the same may from time to time be further amended, modified, supplemented or restated, the Warrant).

B.       Silicon Valley has extended credit to the Company for the purposes permitted in the Loan and Security Agreement dated as of October 26, 2011 between the Company and Silicon Valley Bank, as amended (as amended, the Loan Agreement). In connection therewith, SVB Financial Group and the Company agree to amend the Warrant as set forth herein.


NOW, THEREFORE, in consideration of the foregoing recitals and other good and valuable consideration, the receipt and adequacy of which is hereby acknowledged, and intending to be legally bound, the parties hereto agree as follows;

1.       Definitions. Capitalized terms used but not defined in this Amendment shall have the meanings given to them in the Warrant.

2.       Amendments to Warrant.

2.1       Definitions.

(a)       The following definitions on page 1 of the Warrant are amended and restated in their entirety to read as follows:

Number of Shares: 199,569 shares

Warrant Price: $1.2026

3.       General. Except as amended by the amendments set forth in Section 2 above, the Warrant remains m full force and effect. This Amendment may be executed in any number of counterparts and all of such counterparts taken together shall be deemed to constitute one and the same instrument. This Amendment shall be deemed effective upon the due execution and delivery to SVB Financial Group of this Amendment by each party hereto.

[Signature page follows.]

IN WITNESS WHEREOF, the parties hereto have caused this Second Amendment to Warrant to Purchase Stock to be duly executed and delivered as of the date first written above.




SVB Financial Group




Carbylan Biosurgery, Inc.


/s/ Michael D. Kruse         


/s/ George Daniloff         


  Michael D. Kruse


  George Daniloff




  President and CEO

[Second Amendment to October 26, 2011 Warrant]